Arikayce (amikacin liposome suspension for oral inhalation – Insmed) — Cigna

Initial criteria

• Patient has Pseudomonas aeruginosa in culture of the airway (e.g., sputum culture, oropharyngeal culture, or bronchoalveolar lavage culture); AND
• Medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis.

Approval duration

1 year